GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Price-to-Free-Cash-Flow

Genomtec (WAR:GMT) Price-to-Free-Cash-Flow : N/A (As of Jun. 10, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec Price-to-Free-Cash-Flow?

As of today (2024-06-10), Genomtec's share price is zł12.00. Genomtec's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was zł-0.51. Hence, Genomtec's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Genomtec's Price-to-Free-Cash-Flow or its related term are showing as below:

WAR:GMT's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.12
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Genomtec's Free Cash Flow per Share for the three months ended in Mar. 2024 was zł0.20. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was zł-0.51.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -43.00% per year.

During the past 6 years, Genomtec's highest 3-Year average Free Cash Flow per Share Growth Rate was -29.00% per year. The lowest was -43.00% per year. And the median was -36.00% per year.


Genomtec Price-to-Free-Cash-Flow Historical Data

The historical data trend for Genomtec's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Price-to-Free-Cash-Flow Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genomtec's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Genomtec's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomtec's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Genomtec's Price-to-Free-Cash-Flow falls into.



Genomtec Price-to-Free-Cash-Flow Calculation

Genomtec's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.00/-0.506
=N/A

Genomtec's Share Price of today is zł12.00.
Genomtec's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Genomtec  (WAR:GMT) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Genomtec Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Genomtec's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomtec (WAR:GMT) Business Description

Traded in Other Exchanges
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines